CD8+ T-cell mediated anti-malaria protection induced by malaria vaccines; assessment of hepatic CD8+ T cells by SCBC assay

References

• World Health Organization (WHO): World Malaria Report 2014. http://www.who.int/malaria/publications/world_malaria_report_2014/en/
   Google Scholar
• Nussenzweig RS, Vanderberg J, Most H, Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature 1967; 216:160-2; PMID:6057225
   PubMed Web of Science ®Google Scholar
• Clyde DF, McCarthy VC, Miller RM, Hornick RB. Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am J Med Sci 1973; 266:398-403; PMID:4590095
   PubMed Web of Science ®Google Scholar
• Herrington D, Davis J, Nardin E, Beier M, Cortese J, Eddy H, Losonsky G, Hollingdale M, Sztein M, Levine M, et al. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. Am J Trop Med Hyg 1991; 45:539-47; PMID:1951863
   PubMed Web of Science ®Google Scholar
• Gwadz RW, Cochrane AH, Nussenzweig V, Nussenzweig RS. Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull World Health Organ 1979; 57(Suppl 1):165-73; PMID:120766
   PubMedGoogle Scholar
• Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, Sacci J, de la Vega P, Dowler M, Paul C, et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002; 185:1155-64; PMID:11930326
   PubMed Web of Science ®Google Scholar
• Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, van de Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T, et al. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 2009; 361:468-77; PMID:19641203; https://doi.org/10.1056/NEJMoa0805832
   PubMed Web of Science ®Google Scholar
• Hoffman SL, Billingsley PF, James E, Richman A, Loyevsky M, Li T, Chakravarty S, Gunasekera A, Chattopadhyay R, Li M, et al. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin 2010; 6:97-106; PMID:19946222
   PubMed Web of Science ®Google Scholar
• Epstein JE, Tewari K, Lyke KE, Sim BK, Billingsley PF, Laurens MB, Gunasekera A, Chakravarty S, James ER, Sedegah M, et al. Live attenuated malaria vaccine designed to protect through hepatic CD8 T cell immunity. Science 2011; 334:475-80; PMID:21903775; https://doi.org/10.1126/science.1211548
   PubMed Web of Science ®Google Scholar
• Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 2013; 341:1359-65; PMID:23929949; https://doi.org/10.1126/science.1241800
   PubMed Web of Science ®Google Scholar
• Epstein JE, Paolino KM, Richie TL, Sedegah M, Singer A, Ruben AJ, Chakravarty S, Stafford A, Ruck RC, Eappen AG, et al. Protection against Plasmodium falciparum malaria by PfSPZ Vaccine. JCI Insight 2017; 2:e89154; PMID:28097230; https://doi.org/10.1172/jci.insight.89154
   PubMed Web of Science ®Google Scholar
• Lyke KE, Ishizuka AS, Berry AA, Chakravarty S, DeZure A, Enama ME, James ER, Billingsley PF, Gunasekera A, Manoj A, et al. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proc Natl Acad Sci U S A 2017; 114(10):2711-2716; pii: 201615324; https://doi.org/10.1073/pnas.1615324114
   PubMed Web of Science ®Google Scholar
• Rénia L, Rodrigues MM, Nussenzweig V. Intrasplenic immunization with infected hepatocytes: a mouse model for studying protective immunity against malaria pre-erythrocytic stage. Immunology 1994; 82:164-8; PMID:7913914
   PubMed Web of Science ®Google Scholar
• Doolan DL, Sedegah M, Hedstrom RC, Hobart P, Charoenvit Y, Hoffman SL. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. J Exp Med 1996; 183:1739-46; PMID:8666931
   PubMed Web of Science ®Google Scholar
• White KL, Snyder HL, Krzych U. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. J Immunol 1996; 156:3374-81; PMID:8617963
   PubMed Web of Science ®Google Scholar
• Rodrigues EG, Zavala F, Eichinger D, Wilson JM, Tsuji M. Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria. J Immunol 1997; 158:1268-74; PMID:9013969
   PubMed Web of Science ®Google Scholar
• Miyahira Y, García-Sastre A, Rodriguez D, Rodriguez JR, Murata K, Tsuji M, Palese P, Esteban M, Zavala F, Nussenzweig RS. Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice. Proc Natl Acad Sci U S A 1998; 95:3954-9; PMID:9520474
   PubMed Web of Science ®Google Scholar
• Jobe O, Lumsden J, Mueller AK, Williams J, Silva-Rivera H, Kappe SH, Schwenk RJ, Matuschewski K, Krzych U. Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells. J Infect Dis 2007; 196:599-607; PMID:17624847
   PubMed Web of Science ®Google Scholar
• Chakravarty S, Cockburn IA, Kuk S, Overstreet MG, Sacci JB, Zavala F. CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat Med 2007; 13:1035-41; PMID:17704784
   PubMed Web of Science ®Google Scholar
• Jobe O, Donofrio G, Sun G, Liepinsh D, Schwenk R, Krzych U. Immunization with radiation-attenuated Plasmodium berghei sporozoites induces liver cCD8alpha+DC that activate CD8+T cells against liver-stage malaria. PLoS One 2009; 4:e5075; PMID:19347042; https://doi.org/10.1371/journal.pone.0005075
   PubMed Web of Science ®Google Scholar
• Tsuji M. A retrospective evaluation of the role of T cells in the development of malaria vaccine. Exp Parasitol 2010; 126:421-5; PMID:19944099; https://doi.org/10.1016/j.exppara.2009.11.009
   PubMed Web of Science ®Google Scholar
• Li X, Huang J, Zhang M, Funakoshi R, Sheetij D, Spaccapelo R, Crisanti A, Nussenzweig V, Nussenzweig RS, Tsuji M. Human CD8+ T cells mediate protective immunity induced by a human malaria vaccine in human immune system mice. Vaccine 2016; 34:4501-6; PMID:27502569; https://doi.org/10.1016/j.vaccine.2016.08.006
   PubMed Web of Science ®Google Scholar
• Tse SW, Cockburn IA, Zhang H, Scott AL, Zavala F. Unique transcriptional profile of liver-resident memory CD8+ T cells induced by immunization with malaria sporozoites. Genes Immun 2013; 14:302-9; PMID:23594961; https://doi.org/10.1038/gene.2013.20
   PubMed Web of Science ®Google Scholar
• Fernandez-Ruiz D, Ng WY, Holz LE, Ma JZ, Zaid A, Wong YC, Lau LS, Mollard V, Cozijnsen A, Collins N, et al. Liver-Resident memory CD8+ T cells form a front-line defense against malaria liver-stage infection. Immunity 2016; 4:889-902; PMID:27692609; https://doi.org/10.1016/j.immuni.2016.08.011
   PubMed Web of Science ®Google Scholar
• Schmidt NW, Podyminogin RL, Butler NS, Badovinac VP, Tucker BJ, Bahjat KS, Lauer P, Reyes-Sandoval A, Hutchings CL, Moore AC, et al. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc Natl Acad Sci U S A 2008; 105:14017-22; PMID:18780790; https://doi.org/10.1073/pnas.0805452105
   PubMed Web of Science ®Google Scholar
• Butler NS, Schmidt NW, Harty JT. Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites. J Immunol 2010; 184:2528-38; PMID:20097864; https://doi.org/10.4049/jimmunol.0903529
   PubMed Web of Science ®Google Scholar
• Nganou-Makamdop K, van Gemert GJ, Arens T, Hermsen CC, Sauerwein RW. Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNγ responses of hepatic CD8+ memory T cells. PLoS One 2012; 7:e36508; PMID:22563506; https://doi.org/10.1371/journal.pone.0036508
   PubMed Web of Science ®Google Scholar
• Rodrigues EG, Claassen J, Lee S, Wilson JM, Nussenzweig RS, Tsuji M. Interferon-gamma-independent CD8+ T cell-mediated protective anti-malaria immunity elicited by recombinant adenovirus. Parasite Immunol 2000; 22:157-60; PMID:10672197
   PubMed Web of Science ®Google Scholar
• Chakravarty S, Baldeviano GC, Overstreet MG, Zavala F. Effector CD8+ T lymphocytes against liver stages of Plasmodium yoelii do not require gamma interferon for antiparasite activity. Infect Immun 2008; 76:3628-31; PMID:18519561; https://doi.org/10.1128/IAI.00471-08
   PubMed Web of Science ®Google Scholar
• Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 2008; 8:247-58; PMID:18323851; https://doi.org/10.1038/nri2274
   PubMed Web of Science ®Google Scholar
• Haining WN. The numerology of T cell functional diversity. Immunity 2012; 36:10-2; PMID:22284416; https://doi.org/10.1016/j.immuni.2012.01.006
   PubMed Web of Science ®Google Scholar
• Anastasopoulou EA, Voutsas IF, Papamichail M, Baxevanis CN, Perez SA. MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4(+) T-cells. Oncoimmunology 2016; 5:e1178439; PMID:27622033; https://doi.org/10.1080/2162402X.2016.1178439
   PubMed Web of Science ®Google Scholar
• Prussin C. Cytokine flow cytometry: understanding cytokine biology at the single-cell level. J Clin Immunol 1997; 17:195-204; PMID:9168399
   PubMed Web of Science ®Google Scholar
• Freer G. Intracellular staining and detection of cytokines by fluorescence-activated flow cytometry. Methods Mol Biol 2014; 1172:221-34; PMID:24908309; https://doi.org/10.1007/978-1-4939-0928-5_20
   PubMedGoogle Scholar
• Chen G, Weng NP. Analyzing the phenotypic and functional complexity of lymphocytes using CyTOF (cytometry by time-of-flight). Cell Mol Immunol 2012; 9:322-3; PMID:22635255; https://doi.org/10.1038/cmi.2012.16
   PubMed Web of Science ®Google Scholar
• Horowitz A, Strauss-Albee DM, Leipold M, Kubo J, Nemat-Gorgani N, Dogan OC, Dekker CL, Mackey S, Maecker H, Swan GE, et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med 2013; 5:208ra145; PMID:24154599; https://doi.org/10.1126/scitranslmed.3006702
   PubMed Web of Science ®Google Scholar
• Yao Y, Liu R, Shin MS, Trentalange M, Allore H, Nassar A, Kang I, Pober JS, Montgomery RR. CyTOF supports efficient detection of immune cell subsets from small samples. J Immunol Methods 2014; 415:1-5; PMID:25450003; https://doi.org/10.1016/j.jim.2014.10.010
   PubMed Web of Science ®Google Scholar
• Fujihashi K, McGhee JR, Beagley KW, McPherson DT, McPherson SA, Huang CM, Kiyono H. Cytokine-specific ELISPOT assay. Single cell analysis of IL-2, IL-4 and IL-6 producing cells. J Immunol Methods 1993; 160:181-9; PMID:8459105
   PubMed Web of Science ®Google Scholar
• Miyahira Y, Murata K, Rodriguez D, Rodriguez JR, Esteban M, Rodrigues MM, Zavala F. Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J Immunol Methods 1995; 181:45-54; PMID:7537312
   PubMed Web of Science ®Google Scholar
• Boulet S, Ndongala ML, Peretz Y, Boisvert MP, Boulassel MR, Tremblay C, Routy JP, Sekaly RP, Bernard NF. A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses. J Immunol Methods 2007; 320:18-29; PMID:17222422
   PubMed Web of Science ®Google Scholar
• Anthony DD, Milkovich KA, Zhang W, Rodriguez B, Yonkers NL, Tary-Lehmann M, Lehmann PV. Dissecting the T cell response: proliferation assays vs. cytokine signatures by ELISPOT. Cells 2012; 1:127-40; PMID:24710419; https://doi.org/10.3390/cells1020127
   PubMedGoogle Scholar
• Ma C, Fan R, Ahmad H, Shi Q, Comin-Anduix B, Chodon T, Koya RC, Liu CC, Kwong GA, Radu CG, et al. A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells. Nat Med 2011; 17:738-43; PMID:21602800; https://doi.org/10.1038/nm.2375
   PubMed Web of Science ®Google Scholar
• Ma C, Cheung AF, Chodon T, Koya RC, Wu Z, Ng C, Avramis E, Cochran AJ, Witte ON, Baltimore D, et al. Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy. Cancer Discov 2013; 3:418-29; PMID:23519018; https://doi.org/10.1158/2159-8290.CD-12-0383
   PubMed Web of Science ®Google Scholar
• Pacheco ND, McConnell E, Beaudoin RL. Duration of immunity following a single vaccination with irradiated sporozoites of Plasmodium berghei. Bull World Health Organ 1979; 57(Suppl 1):159-63; PMID:120765
   PubMedGoogle Scholar
• Renggli J, Hahne M, Matile H, Betschart B, Tschopp J, Corradin G. Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity. Parasite Immunol 1997; 19:145-8; PMID:9106820
   PubMed Web of Science ®Google Scholar
• Rodrigues EG, Zavala F, Nussenzweig RS, Wilson JM, Tsuji M. Efficient induction of protective anti-malaria immunity by recombinant adenovirus. Vaccine 1998; 16:1812-7; PMID:9795385
   PubMed Web of Science ®Google Scholar
• Gonzalez-Aseguinolaza G, Van Kaer L, Bergmann CC, Wilson JM, Schmieg J, Kronenberg M, Nakayama T, Taniguchi M, Koezuka Y, Tsuji M. Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J Exp Med 2002; 195:617-24; PMID:11877484
   PubMed Web of Science ®Google Scholar
• Noe AR, Espinosa D, Li X, Coelho-Dos-Reis JG, Funakoshi R, Giardina S, Jin H, Retallack DM, Haverstock R, Allen JR, et al. A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate. PLoS One 2014; 9:e107764; PMID:25247295; https://doi.org/10.1371/journal.pone.0107764
   PubMed Web of Science ®Google Scholar